Adverse Drug Reaction Classification System

ADR Ontology
ADR Term Communication disorder
ADR ID BADD_A08495
ADR Hierarchy
19      Psychiatric disorders
19.19      Communication disorders and disturbances
19.19.01      Communications disorders
19.19.01.008      Communication disorder
Description Disorders of verbal and nonverbal communication caused by receptive or expressive LANGUAGE DISORDERS, cognitive dysfunction (e.g., MENTAL RETARDATION), psychiatric conditions, and HEARING DISORDERS. [MeSH]
MedDRA Code 10061046
MeSH ID D003147
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Communication disorder NOS | Communication disorder | Communication Disorders | Communication Disorder | Communicative Disorders | Communicative Disorder | Communication Disorders, Developmental | Communication Disorder, Developmental | Developmental Communication Disorder | Developmental Communication Disorders | Childhood Communication Disorders | Childhood Communication Disorder | Communication Disorder, Childhood | Communication Disorders, Childhood | Communicative Dysfunction | Communicative Dysfunctions | Dysfunction, Communicative | Dysfunctions, Communicative | Neurogenic Communication Disorders | Communication Disorder, Neurogenic | Neurogenic Communication Disorder | Communication Disorders, Neurogenic | Communication Disabilities | Communication Disability | Disabilities, Communication | Disability, Communication | Acquired Communication Disorders | Acquired Communication Disorder | Communication Disorder, Acquired | Communication Disorders, Acquired
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D01656Paliperidone0.007376%
BADD_D01733Perampanel0.000125%
BADD_D01835Pregabalin0.000202%
BADD_D01888Quetiapine0.000082%
BADD_D01951Risperidone0.000182%
BADD_D02047Sodium oxybate0.000590%
BADD_D02105Tacrolimus0.000653%
BADD_D02150Temozolomide--
BADD_D02247Topiramate0.000075%
BADD_D02329Valproic acid0.001298%
BADD_D02337Varenicline--
BADD_D02346Venlafaxine0.000032%
BADD_D02392Zoledronic acid--
BADD_D02412Octreotide--
BADD_D02451Pimavanserin0.001333%
BADD_D02457Dexmethylphenidate0.000170%
BADD_D02464Fingolimod0.000362%
BADD_D02473Sodium chloride0.000241%
BADD_D02569Magnesium0.000294%
The 2th Page    First    Pre   2    Total 2 Pages